ATE496935T1 - Verfahren zur aufreinigung hydrophober proteine - Google Patents

Verfahren zur aufreinigung hydrophober proteine

Info

Publication number
ATE496935T1
ATE496935T1 AT08707773T AT08707773T ATE496935T1 AT E496935 T1 ATE496935 T1 AT E496935T1 AT 08707773 T AT08707773 T AT 08707773T AT 08707773 T AT08707773 T AT 08707773T AT E496935 T1 ATE496935 T1 AT E496935T1
Authority
AT
Austria
Prior art keywords
purification
hydrophobic proteins
detergent
proteins
hydroxyapatite
Prior art date
Application number
AT08707773T
Other languages
English (en)
Inventor
Christa Tauer
Artur Mitterer
Original Assignee
Baxter Int
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int, Baxter Healthcare Sa filed Critical Baxter Int
Application granted granted Critical
Publication of ATE496935T1 publication Critical patent/ATE496935T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AT08707773T 2007-02-22 2008-02-19 Verfahren zur aufreinigung hydrophober proteine ATE496935T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90280307P 2007-02-22 2007-02-22
PCT/EP2008/001284 WO2008101667A1 (en) 2007-02-22 2008-02-19 Method of purification of hydrophobic proteins

Publications (1)

Publication Number Publication Date
ATE496935T1 true ATE496935T1 (de) 2011-02-15

Family

ID=39346160

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08707773T ATE496935T1 (de) 2007-02-22 2008-02-19 Verfahren zur aufreinigung hydrophober proteine

Country Status (10)

Country Link
US (1) US8293876B2 (de)
EP (1) EP2129684B1 (de)
JP (1) JP5443175B2 (de)
CN (1) CN101616930B (de)
AT (1) ATE496935T1 (de)
AU (1) AU2008217189B2 (de)
CA (1) CA2677023C (de)
DE (1) DE602008004747D1 (de)
HK (1) HK1138290A1 (de)
WO (1) WO2008101667A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011252850B2 (en) 2010-05-14 2016-03-17 Baxalta GmbH OspA chimeras and use thereof in vaccines
EP2625966A1 (de) 2012-02-13 2013-08-14 Bionanoplus, S.L. Nanopartikel mit einem pflanzlichen hydrophoben Protein und wassermischbare nichtflüchtige organische Lösung sowie Verwendungen davon
EP2841098A4 (de) 2012-04-23 2016-03-02 Allertein Therapeutics Llc Nanopartikel zur behandlung von allergien
EP2877206B1 (de) 2012-07-27 2019-11-27 Baxalta GmbH Zusammensetzungen mit chimären ospa-molekülen und verfahren zu ihrer verwendung
SG11201505192RA (en) * 2013-02-28 2015-08-28 Agency Science Tech & Res Chromatographic purification of antibodies from chromatin-deficient cell culture harvests
MX2015013894A (es) * 2013-04-03 2015-12-11 Allertein Therapeutics Llc Composiciones de nanoparticulas novedosas.
JP6147340B2 (ja) * 2013-05-29 2017-06-14 Jsr株式会社 洗浄用組成物、タンパク質精製方法、及びタンパク質
KR102356757B1 (ko) 2013-10-18 2022-02-03 노바셉 이큅먼트 솔루션즈 단백질 정제
CN104710527B (zh) * 2015-02-28 2018-08-24 苏州金盟生物技术有限公司 一种生物制品的内毒素去除方法
JP2020099909A (ja) * 2020-03-17 2020-07-02 ＨＯＹＡ Ｔｅｃｈｎｏｓｕｒｇｉｃａｌ株式会社 処理方法、生産方法およびハイドロキシアパタイト充填剤

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5861A (en) * 1848-10-17 Locking umbrella and parasol
GB8807860D0 (en) * 1988-04-05 1988-05-05 Connaught Lab Pertussis vaccine
US7094391B1 (en) * 1988-10-24 2006-08-22 The University Of Texas System Compositions and methods for administering Borrelia burgdorferi antigens
US5543399A (en) * 1989-08-22 1996-08-06 Hsc Research & Development Limited Partnership Cystic fibrosis transmembrane conductance regulator (CFTR) protein
US6221363B1 (en) 1991-07-11 2001-04-24 Baxter Aktiengesellschaft Vaccine for the prevention of lyme disease
JP3158878B2 (ja) * 1994-07-28 2001-04-23 松下電器産業株式会社 光学式エンコーダ
US5846946A (en) * 1996-06-14 1998-12-08 Pasteur Merieux Serums Et Vaccins Compositions and methods for administering Borrelia DNA
US5861295A (en) 1997-01-02 1999-01-19 Life Technologies, Inc. Nucleic acid-free thermostable enzymes and methods of production thereof
US6152944A (en) * 1997-03-05 2000-11-28 Scimed Life Systems, Inc. Catheter with removable balloon protector and stent delivery system with removable stent protector
GB9811219D0 (en) * 1998-05-26 1998-07-22 Smithkline Beecham Biolog Novel process
BR9913026A (pt) 1998-08-14 2001-09-25 Merck & Co Inc Processo de purificação de partìculas semelhantes a vìrus (vlps) de papilomavìrus recombinante, e, processo de preparação de um produto de vlp de papilomavìrus humano purificado adequado para uso em uma vacina para humano
GB0100513D0 (en) * 2001-01-09 2001-02-21 Smithkline Beecham Plc Process

Also Published As

Publication number Publication date
EP2129684A1 (de) 2009-12-09
WO2008101667A1 (en) 2008-08-28
US20080249014A1 (en) 2008-10-09
CN101616930A (zh) 2009-12-30
DE602008004747D1 (de) 2011-03-10
CA2677023C (en) 2016-08-30
AU2008217189B2 (en) 2013-06-13
US8293876B2 (en) 2012-10-23
EP2129684B1 (de) 2011-01-26
JP5443175B2 (ja) 2014-03-19
HK1138290A1 (en) 2010-08-20
CA2677023A1 (en) 2008-08-28
CN101616930B (zh) 2013-05-08
JP2010518836A (ja) 2010-06-03
AU2008217189A1 (en) 2008-08-28

Similar Documents

Publication Publication Date Title
ATE496935T1 (de) Verfahren zur aufreinigung hydrophober proteine
DE602007009295D1 (de) Verfahren zur vorbereitenden rna-reinigung mittels hplc
BRPI0917993A2 (pt) composições de célula-tronco mesenquimal purificada e métodos de purificação de composições de célula-tronco mesenquimal purificda.
DE602007007666D1 (de) Verfahren zur herstellung von nebivolol
DK1745136T3 (da) Fremgangsmåde til enzymatisk fremstilling af (S)-3-cyano-5-methylhexansyre
ZA200900836B (en) Process for the purification of FC-fusion proteins
DK2084287T3 (da) Fremgangsmåde til biologisk fremstilling af n-butanol med højt udbytte
RS50516B (sr) Prečišćavanje il-18 vezujućeg proteina
ATE408616T1 (de) Verfahren zur aufreinigung von il-18-bindendem protein
DE602008001872D1 (de) Verfahren zur synthese von saccharose-6-estern
ATE529433T1 (de) Verfahren zur reinigung eines il-18-bindenden proteins
DE602005022099D1 (de) Fluorisierungsverfahren zur synthese von 2-ä18fü fluoro-2-deoxy-d-glukose
DK2307116T3 (da) Fremgangsmåde til selektiv ekstraktion af membranproteiner med calixarener
DE602006019870D1 (de) Verfahren zur synthese von triazolen
DE112006000985A5 (de) Verfahren zur Herstellung von Tetrahydropyranen aus Tetrahydropyran-3-onen
DE602007012971D1 (de) Verfahren zur Herstellung von (Meth)Acrylsäure
ATE525466T1 (de) Verfahren und testkit zur trennung, aufreinigung und wiedergewinnung von lang- und kurzkettigen nukleinsäuren
EA201592070A1 (ru) Способ отделения муравьиной кислоты от метилтетрагидрофурана
DK1842908T3 (da) Fremgangsmåde til fremstilling af oprenset lipase
DE502006003169D1 (de) Verfahren zur enzymatischen Synthese von Triglyceriden
DE102006042191A8 (de) Verfahren zur Reinigung von Radium aus verschiedenen Quellen
DE602007001037D1 (de) Verfahren zur Herstellung von Acrylsäure
DE602007005288D1 (de) Verfahren zur Reinigung von Acrylsäure
DE502006003285D1 (de) Verfahren zur auftrennung stereoisomerer verbindungen
IL199752A0 (en) Purification of taci-fc

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties